TOP STORIES

• BUSINESS Meiji to Develop Lineup Unaffected by Price Revisions, Bolster Earnings from New Drugs/Generics in Focus Areas
  July 12, 2023

• REGULATORY MHLW Pharma Regulation Panel Kicks Off, Agrees to Discuss Incentives to Develop Pediatric Drugs
  July 11, 2023

• BUSINESS Shionogi to Cut 200 Jobs via Voluntary Buyout Program
  July 11, 2023

• ORGANIZATION Stop Requiring Japanese PI Data for Global Products: JPMA Officials
  July 10, 2023

• REGULATORY PMDA US Office to Set Out Solution for Drug Lag, Loss: Agency Chief
  July 10, 2023

• BUSINESS Full US Nod in Hand, Eisai CEO Keeps 1 Trillion Yen Sales Target for FY2030
  July 10, 2023

• BUSINESS FDA Awards Full Approval to Eisai’s Alzheimer’s Drug
  July 7, 2023

• REGULATORY Pharma Groups Float New Methods to Evaluate Innovative Drugs for 2024 Reform
  July 6, 2023

• REGULATORY Japan, US, Europe Trade Groups Urge Japan to Abolish “Spillover” Re-Pricing
  July 6, 2023

• BUSINESS Insmed Japan to Capitalize on Arikayce, Pins Hopes on Brensocatib: New President
  July 5, 2023

• BUSINESS Alarmed over Domestic Generics Biz, Sawai Group to Review Long-Term Targets
  July 5, 2023

• BUSINESS Jan Stefan Scheld to Helm Nippon Boehringer Ingelheim
  July 5, 2023

• BUSINESS Chugai Is Best-Paying Japan Pharma Again in FY2022, 5 Drug Makers Top 10 Million Yen
  July 4, 2023

• REGULATORY MHLW to Launch Pharma Affairs Study Group July 10, Drug Loss Up for Debate
  July 4, 2023

• REGULATORY LDP Bigwigs Launch Study Group on Drug Discovery to Spur Innovation
  July 3, 2023

• BUSINESS 32 Pharma Execs Take Home Over 100 Million Yen in FY2022, Top 3 from Takeda: Securities Reports
  July 3, 2023

• REGULATORY MHLW Expert Panel’s Report Serves as Starting Line for Reform: Asst. Vice Minister
  June 30, 2023

• REGULATORY Japan Mulls Narrowing Down COVID-19 Jabs to Pfizer, but Some Lawmakers Are Skeptical
  June 29, 2023

• BUSINESS Chugai Trims 150 Reps via Voluntary Buyout, Sales Force Down to 1,050 from July
  June 29, 2023

• REGULATORY MHLW Shuffles Senior Bureaucrats, Jo Tapped as Chief of Pharma Bureau
  June 28, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 46
• 47
• 48
• 49
• 50
• 51
• 52
• 53
• 54
• …
• Next ›
• 最終 »